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Abstract: 
 Oxidized LDL (oxLDL) may contribute to the accumulation of apoptotic cells in atherosclerotic 
plaques. Although it is well established in monophasic chemical systems that the highly 
unsaturated EPA and DHA will oxidize more readily than FA that contain fewer double bonds, 
our previous studies showed that enrichment of LDL, which has discrete polar and nonpolar 
phases, with these FA did not increase oxidation. The objective of this study was to compare the 
extent of apoptosis induced by EPA/DHA-rich oxLDL to that induced by EPA/DHAnon-rich 
oxLDL in U937 cells. LDL was obtained from one healthy subject three times before and after 
supplementation for 5 wk with 15 g/d of fish oil (FO), an amount easily obtainable from a diet 
that contains fatty fish. After supplementation, an EPA/DHA-rich LDL was obtained. Oxidative 
susceptibility of LDL, as determined by measuring the formation of conjugated dienes and the 
accumulation of cholesteryl ester hydroperoxides, was not higher in EPA/DHA-rich LDL. The 
oxLDL-induced cell apoptosis was detected by the activation of caspase-3, the translocation of 
PS to the outer surface of the plasma membrane using the Annexin V-fluorescein isothiocyanate 
binding assay, and the presence of chromatin condensation and nuclear fragmentation using the 
4,6-diamidino-2-phenylindole staining assay. All three measures showed that after FO 
supplementation, EPA/DHA-rich oxLDL-induced cell apoptosis decreased. The decrease was 
not related to the concentration of lipid hydroperoxides. This study suggests that a possible 
protective effect of EPA/DHA-rich diets on atherosclerosis may be through lessening cell 
apoptosis in the arterial wall. 
Paper no. L8943 in Lipids 37, 789–796 (August 2002). 
 
Article: 
Recent findings show that apoptosis is responsible for much of the cell death seen during 
atherosclerosis. Indeed, apoptosis has been positively correlated with the localization and 
severity of atherosclerosis (1). Macrophages, smooth muscle cells, and lymphocytes undergoing 
apoptosis all have been found in human atherosclerotic lesions (2–4). Of the three cell types, 
macrophages appear to be the preferred cell population in atherosclerotic lesions to undergo 
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apoptosis (2,5,6). Apoptotic macrophages have been implicated in the initiation and enlargement 
of the cellular lipid-core in the advanced atherosclerotic lesion (7–9). Furthermore, this process 
can lead to the activation of thrombosis (7–9). 
 
Oxidized LDL (oxLDL) plays a critical role in the development of atherosclerosis (10,11). 
Recently, oxLDL has been shown to induce apoptosis in human umbilical vein endothelial cells 
(12,13), smooth muscle cells and fibroblasts (14), and macrophages (15,16). 
 
It is conceivable that the role of oxLDL in the development of atherosclerosis could be through 
induction of apoptosis. The mechanisms by which oxLDL induce apoptosis are not well 
understood. Lipid hydroperoxides (17), decomposition products (i.e., 4-hydroxynonenal) (18), 
and cholesterol oxidation products (oxysterols) (i.e., 25-hydroxycholesterol or 7-ß 
hydroxycholesterol) (13,19–21) are generated during oxidation of LDL and have been shown to 
induce apoptosis. However, the relative potencies of these different products are not yet known. 
Furthermore, upregulated Fas and Fasligand (22), the release of cytochrome c from mitochondria 
(21), the activation of caspase-8 (22), caspase-3 (13,15,21), and an increase in cellular calcium 
concentrations (23) have all been implicated in oxLDL-induced cell apoptosis. 
 
Current research has attempted to identify those factors that regulate the oxidation of LDL and 
the production of its decomposition products. It is believed that an improved understanding of 
these factors may provide a therapeutic tool for controlling the development and progression of 
atherosclerosis. For example, dietary FA influence the rate and extent of LDL oxidation. EPA 
and DHA are FA mainly from fish that are associated with a decreased risk of cardiovascular 
disease. In a recent clinical trial, results showed that enriching LDL with EPA/DHA produced a 
lower concentration of lipid hydroperoxides compared to the LDL enriched with linoleic acid 
(24), when LDL was subjected to oxidation. Given that lipid hydroperoxides are the predominant 
lipid oxidation products found in atherosclerotic lesions (25), our findings support a role of 
EPA/DHA in reducing the severity of atherosclerosis. Moreover, reduced production of lipid 
hydroperoxides may lessen the formation of secondary oxidation products such as 4- 
hydroxynonenal, thereby reducing apoptosis. 
 
The effect of oxidized LDL that has been enriched with EPA/DHA on cell apoptosis has not 
been investigated. In order to evaluate this, the oxidative susceptibility of EPA/DHA-rich LDL 
was compared to that of EPA/DHA-nonrich LDL. The extent of apoptosis of U937 cells induced 
by 
EPA/DHA-rich oxLDL was compared to that of EPA/DHAnon-rich oxLDL. U937 cells are 
human pro-monocytic cells and share many characteristics with macrophages. Additionally, they 
are one of the easiest cell models in which to study apoptosis. EPA/DHA-rich oxLDL contained 
less or equivalent concentrations of lipid hydroperoxides as did EPA/DHAnon-rich oxLDL. 
Apoptosis of U937 cells was induced after 6–7 h of incubation with oxLDL, and was lower in 
cells treated with EPA/DHA-rich oxLDL compared to cells treated with EPA/DHA-non-rich 
oxLDL. 
 
MATERIALS AND METHODS 
Supplementation and experimental design 
The University of North Carolina at Greensboro Institutional Review Board approved the current 
study, and the subject signed informed consent prior to entering the study. A healthy, 
nonsmoking male (37 yr) was supplemented with 15 g/d fish oil (FO) for 5 wk. Plasma was 
collected on three separate days before and after supplementation. The FA profile of the oil was 
measured by GC using heptadecanoic acid (Nu-Chek-Prep, Elysian, MN) as an internal standard 
as previously described (26). The supplement (15 g) provided 1.26 g EPA and 1.08 g DHA. This 
amount (2.34 g) of n-3 FA is similar to that found in two servings (200 g) of Chinook salmon 
(27). FO supplements were kindly provided by OmegaPure
TM
 (Houston, TX) in bulk and were 
then encapsulated by Banner Pharmacaps, Inc. (High Point, NC). A mixture of α-, γ-, and δ-
tocopherols (courtesy of ADM Nutraceuticals, Decatur, IL) and TBHQ (Eastman Chemical 
Company, Kingsport, TN) were added to the oil. The vitamin E content of the oil was measured 
by HPLC (Agilent Technologies 1100 series, Palo Alto, CA) using a fluorometric detector set at 
292 nm for excitation and 330 nm for emission (28). Recovery of α-tocopherol added to the 
sample was 92%, and the interassay coefficient of variation was 5.6%. After these additions, the 
oil contained 0.540 mg α-tocopherol/g oil, 0.689 mg γ-tocopherol/g oil, 0.177 mg δ-tocopherol/g 
oil, and 0.02% TBHQ. 
 
Cell culture and treatment 
A week before the experiments, U937 cells (ATCC, Rockville, MD) were thawed from the 
frozen vials and maintained at 1–5 × 10
5
/mL cells in T-75 culture flasks in RPMI 1640 medium 
supplemented with 10% FBS, 1% glutamine (200 mmol/L), 1% penicillin-streptomycin (10,000 
IU/mL), and 0.2% amphotericin B (250 µg/mL) at 37°C in a 95% air/5% CO2 humidified 
incubator. These cells were used in subsequent experiments. Preparation of lipoproteins and 
determination of LDL oxidative susceptibility. Blood samples were collected into Vacutainer
®
 
tubes (Beckton Dickinson, Franklin Lakes, NJ) containing Na2EDTA (1 g/L) after an overnight 
fast (≥10 h). Plasma was immediately isolated by centrifugation at 1200 × g for 15 min at 4°C 
(Jouan GR 4-12, Winchester, VA). An aliquot of plasma was stored at −80°C for later 
measurement of the lipid profile. The lipid profile, including plasma concentrations of 
cholesterol, triacylglycerol (TAG), HDL-cholesterol (HDL-C), and LDL-cholesterol (LDL-C), 
were measured to ensure that the subject was normolipemic. Plasma concentrations of 
cholesterol and TAG were measured as previously described (29). The cholesterol concentration 
of the HDL fraction was measured by an enzymatic method in samples after the precipitation of 
the LDL and VLDL fractions with phosphotungstic acid in conjunction with MgCl2 (Sigma Kit 
#352-4, St. Louis, MO) (30). LDL-C concentration was calculated using the following formula: 
total cholesterol − HDL-C 
– TAG/5 (31). LDL was isolated from plasma by centrifugation using a modification of the 
method of Chung et al. (32) as modified by Chen and Loo (33). Briefly, 28 mL of NaCl (0.195 
M) was carefully overlaid on 11.5 mL of plasma in a 39.5 mL tube (Beckman, Quick-seal‚ Palo 
Alto, CA). The ultracentrifuge tube was placed in a 50.2 Ti rotor (Beckman) and centrifuged at 
190,000 × g (40,000 rpm) for 2 h in a Beckman L7-65 ultracentrifuge. 
 
An aliquot of the isolated LDL was stored at −80°C for measurement of the FA profile. The FA 
profile was measured by GC as previously described (26) using heptadecanoic acid (NuChek-
Prep) as an internal standard. Following removal of EDTA and KBr from a second aliquot of 
LDL by using a 10 DG disposable column (Bio-Rad Laboratories, Hercules, CA), the cholesterol 
concentration was determined enzymatically as previously described (29) and is referred to as 
LDL-C. 
 
The EDTA/KBr-free LDL was oxidized; and cholesteryl ester hydroperoxide (CEOOH) 
concentration, apoptotic events, and conjugated diene formation were measured. CEOOH and 
apoptosis were measured in aliquots taken from the same oxidized solution. In this system 0.4 
mg LDL-C/mL was oxidized with 5 µM Cu
2+
. The formation of conjugated dienes was measured 
in a separate system by continuously monitoring their production at 234 nm in a Beckman DU-
640 spectrophotometer, as we have previously reported (34), at 37°C over a 6-h time period. The 
concentration of conjugated dienes was calculated using the molar extinction coefficient 29,500 
M
−1
cm
−1
 (35). The three variables—lag time, rate of oxidation, and maximal concentration of 
conjugated dienes— were determined. Maximal rate was determined to be the slope of the line of 
best fit through the points that defined the steepest slope of the curve. The length of the lag phase 
was determined to be the time (value for x) at the intersection of the line describing the maximal 
rate and the line describing the initial rate. The maximal concentration was determined from the 
maximum absorption measured during the 6-h oxidation. The absorption at 234 nm plateaued at 
about 5 h and then began to decrease, indicating that secondary oxidation products were being 
formed as the conjugated dienes degraded. As many products are formed during this time and 
their absorptivity is unknown, monitoring the absorbance at 234 nm would yield ambiguous 
results and was terminated at 6 h. The maximal rate of formation and the concentration of 
conjugated dienes were expressed relative to the protein content of the EDTA/KBr-free LDL. 
The protein content of the LDL was determined using a kit obtained from Bio-Rad Laboratories. 
It was previously determined that optimal performance for the measurement of conjugated dienes 
was obtained when 55 µg LDL protein/mL (0.25 mg LDL/mL) was used (34). However, to make 
comparisons between the system in which CEOOH and apoptosis were measured and that in 
which conjugated dienes were measured, the ratio of Cu 
2+
 to LDL-C had to be constant. This 
was accomplished by measuring the protein content of the EDTA/KBr-free LDL and diluting it 
to 55 µg protein/mL. Because the dilution factor was known, the concentration of cholesterol in 
this diluted solution could be calculated. Once the cholesterol concentration was known, the 
concentration of CuSO4 needed to maintain consistency across both systems could be calculated. 
This calculation was made for each sample. 
 
To measure CEOOH concentration and apoptosis in the EDTA/KBr-free LDL sample before 
oxidation was initiated by the addition of CuSO4, a sample of LDL was removed and EDTA (1.5 
mg/mL) was immediately added to prevent oxidation. This sample is identified as native LDL 
(nLDL). The remaining EDTA/KBr-free LDL was oxidized. An aliquot was removed after 6 h, 
and EDTA (1.5 mg/mL) was added immediately to halt the oxidation reactions. The remaining 
EDTA/KBr-free LDL sample was oxidized four more hours (a total of 10 h), and again EDTA 
was added to terminate the oxidation reactions. HPLC with an isoluminol-dependent 
chemiluminescence detection method, as previously reported (24), with slight modification was 
used to analyze nLDL, 6-h oxLDL, and 10-h oxLDL for CEOOH formation. Briefly, nLDL and 
oxLDL were extracted with hexane, evaporated, and dissolved in ethanol. Samples were injected 
onto a C-18 column (Supelcosil LC-18, 5 µm, 250 × 4.6 mm; Supelco, 
Bellefonte, PA) using a mobile phase of methanol/tertbutanol (1:1, vol/vol) at a flow rate of 1.0 
mL/min. A postcolumn chemiluminescence reagent consisting of 3:7 (vol/vol) methanol to 100 
mM sodium borate buffer (pH 10) containing 1 mM isoluminol (6-amino-2,3-dihydro-1,4-
phthalazinedione; Sigma), and 3 mg/L microperoxidase (MP-11; Sigma) at a flow rate of 1.5 
mL/min was added to the eluent. Cholesteryl linoleate hydroperoxide (CE 18:2OOH) (Cayman 
Chemicals, Ann Arbor, MI) was used as an external standard to quantify the amount of 
CE18:2OOH present in the samples. The modifications gave a single peak from CEOOH rather 
than several peaks, each associated with a different CEOOH, as reported previously (24). Thus, a 
more global assessment of the oxidation of core lipids was obtained. 
 
Apoptosis assays  
Apoptosis was assessed by three methods: caspase-3 activity, translocation of PS, and condensed 
chromatin and nuclear fragmentation. In the caspase-3 method, acetyl-asp-glu-val-asp-
aminomethyl coumarin (Ac-DEVDAMC), a synthetic tetrapeptide fluorogenic substrate, was 
added to the samples. This substrate is cleaved in the presence of caspase-3, releasing the 
fluorescent AMC moiety, which can be quantified by fluorescence intensity 
spectrophotometrically (36) (PharMingen #6332K, San Diego, CA). For the second method, 
translocation of PS from the inner to the outer leaflet of the plasma membrane was measured by 
the Annexin V binding assay. In this assay Annexin V conjugated to fluorescein isothiocyanate 
(FITC) binds to the translocated PS, and the amount of the conjugate can be quantified 
fluorometrically. This assay can be used as a marker of early apoptosis (37). In addition, in this 
assay cells were costained with propidium iodide (PI). This is used as a marker for cell 
membrane permeability, a change that occurs during the latter stages of apoptosis and in 
necrosis. Viable and early apoptotic cells, which have intact membranes, exclude PI, but necrotic 
cells do not. Apoptotic cells are FITC-positive and PI-negative, whereas necrotic cells are both 
FITC- and PI-positive. In the third assay, condensed chromatin and nuclear fragmentation were 
visualized microscopically after staining the cells with the fluorescent dye 4,6-diamidino-2-
phenylindole (DAPI). 
 
All three measures of apoptosis were made before and after supplementation with FO. Each 
treatment was performed in triplicate. The cells were incubated with unoxidized LDL (nLDL), 
LDL that was oxidized for 6 h (6-h oxLDL), and LDL that was oxidized for 10 h (10-h oxLDL). 
The concentration of LDL-C was maintained at 66 µg/mL for caspase-3 activity and DAPI 
staining measurements and 133 µg/mL for PS translocation. Incubations with the LDL were 6–7 
h long. All experiments included positive and negative controls. For the negative control, cells 
were incubated in LDL-free medium. Two positive controls were used. One positive control was 
to treat the cells with 25-hydroxycholesterol (62.5–66.7 µg/mL) (Sigma-Aldrich, St. Louis, MO) 
for 6 h. The other one was to treat them 
with (1.5 µg/mL) camptothecin (Sigma-Aldrich) for 4 h. A shorter incubation was used for the 
camptothecin because it induced apoptosis more quickly. Since the supplementation lasted about 
5 wk, the LDL that was enriched with EPA/DHA was obtained later than the LDL that was not 
enriched with these FA. The use of these two positive controls allowed us to establish that the 
U937 cells behaved in a similar fashion at both times.  
 
For the measurement of caspase-3 activity, 5 × 10
5
 cells were incubated with the negative and 
two positive controls, nLDL, 6-h oxLDL, and 10-h oxLDL. Cells were harvested and washed 2× 
with PBS (pH 7.4, 10 mmol/L), resuspended in lysis buffer (100 µL buffer/L × 10
6
 cells), and 
stored at −20°C for batch analysis. Samples were analyzed using a fluorescence 
spectrophotometer (PerkinElmer LS 5OB, Norwalk, CT) set at 380 nm for excitation and 420 nm 
for emission. Data are expressed as relative fluorescent intensity per 10
5
 cells. 
 
For the measurement of translocation of PS, 2.5 × 10
5
 cells were incubated in the same six 
systems: the negative and positive controls, nLDL, 6-h oxLDL, and 10-h oxLDL. After in-
cubation, 0.3 mL of the cell suspension was removed from each well and washed 2× with ice-
cold PBS (Ca 
2+
 :Mg 2+- 
free). The resulting cell pellet was suspended in 0.1 mL binding buffer [10 mmol/L 
HEPES/NaOH (pH 7.4), 140 mmol/LNaCl, 2.5 mmol/L CaCl2], 5 µL of Annexin V-FITC (as 
supplied by PharMingen #65874x, San Diego, CA), and 10 µL of PI stock solution (50 µg/mL) 
and then incubated in the dark for 15 min. After incubation, an additional 0.4 mL aliquot of 
binding buffer was added to the cell solution. Cells were analyzed with a FACS Calibur flow 
cytometer (Becton Dickinson, San Jose, CA) using the FL1 channel to detect the signal 
generated by Annexin V-FITC and the FL2 channel to detect the signal generated by PI. Data are 
expressed as the percentage of cells positively stained with Annexin V-FITC but negatively 
stained with PI. 
 
For the DAPI staining assay 2.5 x 10
5
 cells were incubated with native LDL, 10-h oxLDL, and 
the controls. Cells were harvested and washed 2x with PBS (pH 7.4, 10 mmol/L) before being 
resuspended in 200 µL of PBS and loaded on poly-Llysine slides (Sigma #P-0425) in Cytospin 
Chambers (StatSpin, Inc. #CC03, Norwood, MA) for 10 min. Slides were cytospun in a 
Cytofuge
®
2 (StatSpin, Inc.) for 4 min at 850 rpm (40 x g), immersed in fresh 3.7% formaldehyde 
solution for 20 min at 4°C, and subsequently stored at least one night in ice-cold 70% ethanol at 
—20°C. Following storage, slides were washed 3x with PBS, immersed into a diluted DAPI 
solution (1 µg/mL) for 10 min, and then viewed on an Olympus BX-60 fluorescence microscope 
(Melville, NY) equipped with a SPOT digital camera (Sterling Heights, MI). The excitation 
wavelength was 358 nm, and the emission wavelength was 461 nm. The apoptotic cells were 
identified by a bright blue nucleus, characteristic of either condensed or fragmented chromatin, 
whereas normal cells were characterized by a faint blue nucleus. At least 80 cells were counted 
from three randomly selected fields on each slide. Slides were examined for each sample. The 
percentage of apoptotic cells was calculated by dividing the number of apoptotic cells by the 
total number of cells x 100%. 
 
Statistical analysis 
The significance of supplementation with FO on the lipid profile, the FA profile, and LDL oxida-
tive susceptibility was determined using a two-sample t-test (38). The repeated measure’s 
procedure was used to determine statistically significant differences between time points as well 
as the FO supplements on CEOOH concentration (38). To determine the influence of the length 
of time that LDL was oxidized on the extent of apoptosis, the data were analyzed using a one-
way ANOVA (38). When a significant difference was found, pair-wise comparisons were 
performed using the Tukey–Kramer test to determine significant differences among treatments 
(38). To determine the effect of FO supplementation on extent of apoptosis, a two-sample t-test 
was used (38). All experiments were repeated three times before and after supplementation. 
Analyses were completed using the SAS general linear model procedure (version 8; SAS In-
stitute Inc., Cary, NC). A value of P < 0.05 was considered significant. 
 
RESULTS 
The TAG concentration in plasma was reduced (P = 0.02) from baseline by 51% after FO 
supplementation. The FO supplementation did not significantly (P > 0.05) alter the concentration 
of cholesterol, HDL-C, or calculated cholesterol in LDL. The LDL FA profile changed after 
supplementation with FO (Fig. 1). The concentration of EPA (20:5n-3) and DHA (22:6n3) in 
LDL was 1100 and 110% higher after supplementation, respectively, compared to baseline (P < 
0.05 for both FA). 
 
The lag time and maximal rate of production for conjugated dienes were significantly (P < 0.05) 
different from baseline after FO supplementation (Table 1). The lag time was reduced by 32 min, 
and the maximal rate of production for conjugated dienes was reduced by 37%. However, the 
maximal amount of conjugated dienes produced in the LDL was similar (P > 0.05) after FO 
supplementation compared to baseline. 
 
The concentration of CEOOH in LDL both before and after supplementation with fish oil, i.e., 
the concentration in nLDL, was less than 180 pmol/mg LDL-C, the lower limit of detection of 
this assay (Fig. 2). The concentration of CEOOH produced in LDL oxidized for 6 h was 35% 
lower (P = 0.007) after FO supplementation than before FO supplementation. In contrast, the 
concentration of CEOOH in the LDL before and after FO supplementation was statistically 
equivalent in the samples oxidized for 10 h (P > 0.05) (Fig. 2). 
 
For all measures of apoptosis, the response seen in the negative controls, i.e., those cells 
incubated in LDL-free medium (Fig. 3), was similar to the response seen in U937 cells treated 
with nLDL, suggesting that LDL did not initiate apoptosis. There were no significant differences 
(P > 0.05) before and after FO supplementation for U937 cells treated with either 25-
hydroxycholesterol or camptothecin, regardless of which measure of apoptosis was used. This 
suggests that the apoptotic response of the U937 cells was similar even when measures were 
separated by the 5-wk supplementation interval. 
 
Two statistical assessments of the data were performed. One was to determine if the extent of 
apoptosis was influenced by the length of time that LDL was oxidized. This comparison was 
made separately for the samples obtained before and after supplementation with FO. The second 
evaluation was to determine if the supplementation with FO influenced the extent of apoptosis 
induced by LDL after the LDL was oxidized for a defined time. 
 
Influence of length of time that LDL was oxidized on extent of apoptosis 
For all three measures of apoptosis, oxidation of LDL increased the extent of apoptosis (Fig. 3). 
Both before and after supplementation with FO, the activity of caspase-3 was higher in cells 
treated with LDL oxidized for 6 or 10 h compared to cells treated with nLDL (P = 0.0001 in all 
comparisons except for cells treated with LDL oxidized for 6 h after FO supplementation, where 
it was 0.0324). However, although 
 
FIG. 1. FA concentration in LDL before (open bars) and after (solid bars) supplementation with fish oil. Data 
are least square means (LSM) ± SEM. Bars with different letters above them for each FA are significantly 
different, P<_ 0.05. 
 
Table 1: Lag Time, Rate of Formation of Conjugated Dienes, and Maximum Production of Conjugated 
Dienes in LDL 
Before and After Supplementation with Fish Oil' 
Maximum rate 
                                                                                    (nmol/mg LD        Maximum production 
                                                Lag time (min)   protein/min)        (nmol/mg LDL protein) 
Before FO 140 ± 2 1.87 ± 0.08 186 ± 17 
After FO 108 ± 2 1.17 ± 0.08 171 ± 17 
Before FO vs. after FO 
(Pvalues)
b
 
0.0002 0.0032 0.5749 
 
a
Least square means (LSM) ± SEM calculated for triplicate determinations made from three independent 
experiments. bP value from two-sample t-test. 
 
the activity of caspase-3 was higher in the cells treated with LDL oxidized for 10 h compared to 
those treated with LDL oxidized for 6 h before supplementation with FO (P = 0.0001), its 
activity was statistically equivalent in those cells treated with LDL oxidized for 6 and 10 h after 
supplementation with FO. 
 
In using the Annexin V assay, both before and after supplementation with FO, the percentage of 
apoptotic cells was higher in cells treated with LDL oxidized for 6 and 10 h (P = 0.0001) 
compared to cells treated with nLDL. However, in contrast to the caspase-3 assay, the extent of 
apoptosis was significantly higher in the cells treated with LDL oxidized for 10 h compared to 
LDL oxidized for 6 h both before (P = 0.0001) and after FO supplementation (P = 0.0033). 
In using the DAPI staining assay both before and after FO supplementation, the percentage of 
apoptotic cells was higher in cells treated by LDL oxidized for 10 h compared to cells treated 
with nLDL (P = 0.0001). 
 
Influence of FO supplementation on extent of apoptosis 
Apoptosis induced by oxLDL, regardless of assay used, was decreased by FO supplementation. 
The activity of caspase-3 in U937 cells treated with LDL oxidized for 6 and 10 h after 
supplementation with FO was reduced by 13 (P = 0.0053) and 22% (P = 0.0001), respectively, 
compared to treatment with LDL oxidized for the same length of time but obtained before 
 
FIG. 2. Lipid peroxidation before (open bars) and after (solid bars) supplementation with fish oil as indicated 
by the concentration of cholesteryl ester hydroperoxides in LDL. Each of the labels on the x-axis are defined 
as follows: nLDL, native LDL, is the LDL sample before any oxidation has occurred; 6-h oxLDL represents 
LDL oxidized for 6 h with copper; 10-h oxLDL represents LDL oxidized for 10 h. Data are least square 
means (LSM) ± SEM. Bars with different letters above them at each time for LDL oxidation are significantly 
different, P<_ 0.05. 
 
supplementation with FO (Fig. 3A). On the basis of the Annexin V assays, only after the LDL 
had been oxidized for 10 h was a significant difference measured in the extent of apoptosis 
before and after FO supplementation. It was 30% lower (P < 0.0001) in U937 cells treated with 
EPA/DHA-rich LDL compared to EPA/DHA-non-rich LDL oxidized for 10 h (Fig. 3B). Results 
from the DAPI staining assays showed a 61% reduction (P = 0.0001) in apoptosis for U937 cells 
treated with LDL oxidized for 10 h after FO supplementation compared to before 
supplementation (Fig. 3C). 
 
DISCUSSION 
Apoptotic vascular cells have been found in atherosclerotic lesions (2–4). Since oxLDL has been 
reported to induce apoptosis of endothelial cells (12,13), smooth muscle cells and fibroblasts 
(14), and macrophages (15,16) in vitro, it may be a candidate for the induction of apoptosis of 
vascular cells in vivo. The oxidized lipids in oxLDL are thought to be responsible for apoptosis. 
Thus, events that modify the bioactive lipid profile of oxLDL may affect its ability to induce 
apoptosis. We showed in this study and previously (24,34) that LDL enriched with EPA and 
DHA has the intuitively predicted shorter lag time, suggesting increased oxidative susceptibility, 
but a paradoxical decrease in rate of formation of conjugated dienes, suggesting decreased 
oxidative susceptibility. The explanation that we have offered is that bicycloendoperoxides are 
formed in the presence of EPA and DHA and that they rapidly migrate to the surface of the LDL 
particle because of their polarity. Thus, since radicals are removed from the system, the rate of 
the propagation is slowed. These reactions would alter the lipid entities present in oxLDL that 
would induce apoptosis. Thus, the purpose of this study was to determine if EPA/DHA-rich 
oxLDL, obtained after FO supplementation, altered the extent of apoptosis as compared to the 
LDL obtained prior to FO supplementation. Several standard apoptotic markers were used to 
provide a better confirmation of apoptosis. The results showed that oxLDL induced apoptosis in 
U937 cells, as characterized by the activation of caspase-3, translocation of PS, and chromatin 
condensation and nuclear fragmentation. However, LDL obtained after supplementation with FO 
and then oxidized induced less apoptosis than LDL obtained before supplementation with FO. 
 
LDL enriched with EPA/DHA and oxidized for 10 h induced significantly less apoptosis in U937 
cells by all three measures used. However, when the U937 cells were treated with LDL oxidized 
for 6 h, the decrease was significant only when measured by caspase-3 activity. Caspase-3 causes 
the proteolysis of several substrates (39) and thereby brings about the characteristic 
morphological changes seen in apoptosis, such as the alteration of the cellular membranes and 
nuclei (40). Thus, the activation of caspase-3 occurs before the translocation of PS, chromatin 
condensation, or nuclear fragmentation. That the EPA/DHA-rich LDL oxidized for a shorter 
period of time (6 h) did not cause significant differences in the changes of the translocation of PS 
suggests that the changes in translocation of PS induced by the presence of these FA may require 
the activation of caspase-3 and occur after the activation of caspase-3 (41). It does not eliminate 
the possibility that other pathways are also associated with the translocation of PS and are 
triggered by oxLDL containing EPA/DHA. The release of cytochrome c from mitochondria (21), 
the activation of caspase-8 (22) and caspase-3 (13,15,21), and an increase in cellular calcium 
concentrations (23) all have been implicated in oxLDL-induced cell apoptosis. Whether they 
work together with caspase-3 or independently is not known. 
Although the extent of apoptosis was higher in the cells treated with LDL oxidized for 10 h than 
LDL oxidized for 6 h, the concentration of CEOOH was higher in the LDL oxidized for 6 h than 
that in LDL oxidized for 10 h. This divergence suggests that CEOOH were not the causative 
agents. In this study, the concentration of conjugated dienes reached its maximum value after 
approximately 5 h of oxidation. It is well-established (35) that by the time the concentration of 
conjugated dienes plateaus, secondary oxidation products have begun to form. However, since 
secondary oxidation products were not measured in this study, it cannot be concluded that they 
were the causative factor. 
 
 
 
 
 
 
 
 
 
FIG. 3. Measurement of apoptosis in U937 cells induced by LDL. Cells were incubated with nLDL; 6-h 
oxLDL; and 10-h oxLDL. Cells were incubated without LDL (free LDL) as a negative control. They were 
incubated with 25-hydroxycholesterol (25-OH) or camptothecin (Camp) as positive controls. Two statistical 
assessments of the data were performed. One was to determine if the extent of apoptosis was influenced by 
the length of time that the LDL was oxidized. This comparison is discussed in the text. The second evaluation 
was to determine if the supplementation with fish oil influenced the extent of apoptosis induced by LDL 
oxidized for a defined length of oxidation (open bars, before supplementation with fish oil; solid  bars, after 
supplementation). The results from this comparison are represented here. (A) Measurement of activity of 
caspase-3. The activity of caspase-3 was expressed as fluorescence intensity per 105 cells. (B) Measurement of 
U937 cells positively stained with Annexin V–fluorescein isothiocyanate (FITC), negatively stained with 
propidium iodide. Data are displayed as the percentage of 104 cells stained with Annexin VFITC. (C) 
Measurement of 4,6-diamidino-2-phenylindole (DAPI) staining of U937 cells. Apoptotic cells were 
characterized by a bright blue nucleus and condensed and fragmented chromatin. Data are least square 
means (LSM) ± SEM. Bars with different letters above them have a significant effect produced by the fish oil 
supplementation, P<_ 0.05. For other abbreviations see Figure 2. 
 
The suggestion that the CEOOH generated by oxLDL were not responsible for mediating cell 
apoptosis is indirectly supported by Lizard et al. (19) and Harada-Shiba et al. (13). Both of these 
groups of investigators showed that oxysterols induced apoptosis in smooth muscle and 
endothelial cells. Liu et al. (18) also showed that a different form of secondary products, i.e., 4-
hydroxynonenal, induced apoptosis in smooth muscle cells. However, Siow et al. (14) reported 
more apoptotic events in smooth muscle cells at the point of greatest lipid hydroperoxide 
production compared with secondary lipid oxidation products, i.e., aldehydes and ketones. The 
divergence among the above findings may reflect differences in the degree of LDL oxidation 
and/or the fact that a thorough evaluation of secondary oxidation products was not done. 
A strength of this study is that the concentration of lipid hydroperoxides, CEOOH, was measured 
directly via HPLC with an isoluminol-dependent chemiluminescence detection method. This is 
among the most sensitive methods for detecting lipid hydroperoxides directly, rather than their 
presence being inferred, as is done with other measures. It clearly showed CEOOH was not the 
major compound responsible for apoptosis. 
 
In conclusion, we have demonstrated that enrichment of oxLDL with EPA/DHA, obtained after 
supplementing a human with FO, protected U937 cells against oxLDL-induced apoptosis and 
was not related to the concentration of CEOOH. However, the oxLDL used in these studies may 
not simulate oxLDL in vivo. Thus, the relevance of the data collected in this study to explain the 
bioactivity of oxLDL in vivo 
is unknown. Although copper is frequently used to mediate LDL oxidation, it may not be a 
physiologically relevant initiator for LDL oxidation. LDL oxidized ex vivo with copper may 
provide insight into the impact on the oxidation of LDL and vascular walls in vivo that occurs 
when individuals consume diets rich in EPA and DHA. This study suggests that an increased 
concentration of EPA/DHA in LDL may influence its oxidative susceptibility and subsequent 
pathology and that the major compounds responsible for apoptosis are not CEOOH. 
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